The Global Health Body Sounds Concern Over Severe Scarcity of Weight-Loss Jabs

Less than one in 10 individuals who could benefit from weight-loss injections such as Wegovy can access them, caution the global health agency as it publishes its first recommendations on the drugs.

Considering over a billion individuals worldwide currently obese, it is urging increased and just availability to these injectable treatments.

Based on forecasts, more than two billion will be obese by 2030 without intervention.

"The new guidelines recognises that obesity is a chronic disease that can be managed with comprehensive and continuous treatment," stated its chief Tedros Adhanom Ghebreyesus.

Substantial prices, insufficient output, and logistical bottlenecks are significant obstacles to widespread access to the treatments that can help people shift significant weight, says the organization.

Weight-Loss Drug Supply Crisis

Even under the present most optimistic case, the supply of such drugs could only cover around 100 million people – under 10% of those who need them, per the health organization.

The recommendation encourages governments and firms to widen availability, through approaches including voluntary licensing.

The intellectual property rights on a key compound – the primary ingredient of the drug Wegovy – is scheduled to end in several nations in 2026.

How Obesity Jabs Work

The injections imitate a biological compound to slow digestion, reduce hunger and increase feelings of fullness so individuals consume fewer calories.

People typically begin shedding pounds after several weeks of beginning the weekly injections.

Studies indicates people may put most of the weight back on within a year of halting the medication, because their normal food cravings return.

To be overweight or obese elevates your risk for experiencing health problems, including diabetes, cardiovascular issues, brain attack, and certain cancers.

Excess weight concerns individuals in countries worldwide and was responsible for over three and a half million fatalities worldwide in 2024, according to the WHO.